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An evolving view of the eukaryotic oligosaccharyltransferase
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Accepted on November 23, 2005
Asparagine-linked glycosylation (ALG) is one of the most
common protein modification reactions in eukaryotic cells,
as many proteins that are translocated across or integrated
into the rough endoplasmic reticulum (RER) carry N-linked
oligosaccharides. Although the primary focus of this review
will be the structure and function of the eukaryotic oligosac-
charyltransferase (OST), key findings provided by the
analysis of the archaebacterial and eubacterial OST homo-
logues will be reviewed, particularly those that provide
insight into the recognition of donor and acceptor sub-
strates. Selection of the fully assembled donor substrate will
be considered in the context of the family of human diseases
known as congenital disorders of glycosylation (CDG). The
yeast and vertebrate OST are surprisingly complex hetero-
oligomeric proteins consisting of seven or eight subunits
(Ost1p, Ost2p, Ost3p/Ost6p, Ost4p, Ost5p, Stt3p, Wbp1p,
and Swp1p in yeast; ribophorin I, DAD1, N33/IAP, OST4,
STT3A/STT3B, Ost48, and ribophorin II in mammals).
Recent findings from several laboratories have provided
overwhelming evidence that the STT3 subunit is critical for
catalytic activity. Here, we will consider the evolution and
assembly of the eukaryotic OST in light of recent genomic
evidence concerning the subunit composition of the enzyme
in diverse eukaryotes.
Key words: dolichol/endoplasmic reticulum/N-linked 
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Introduction
In eukaryotic cells, a critical step in asparagine-linked glyc-
osylation (ALG) of proteins is catalyzed by the oligosac-
charyltransferase (OST), an integral membrane protein that
mediates the en bloc transfer of a preassembled high-man-
nose oligosaccharide onto asparagine residues of nascent
polypeptides entering the lumen of the rough endoplasmic
reticulum (RER). The dolichol pyrophosphate-linked oli-
gosaccharide (OS-PP-Dol) donor (Glc3Man9GlcNAc2-PP-
Dol in higher eukaryotes) for glycosylation is sequentially
assembled by glycosyltransferases located on the cytoplas-
mic and lumenal faces of the RER membrane. The assem-
bly pathway for dolichol oligosaccharides has been
reviewed in detail (Burda and Aebi, 1999), so here we will
focus on recent discoveries that impact donor-substrate rec-
ognition, selection and catalysis by the OST. Although the
OST has been the focus of a several reviews during the past
decade (Silberstein and Gilmore, 1996; Knauer and Lehle,
1999; Dempski and Imperiali, 2002; Yan and Lennarz,
2005), recent developments in this field make this review
timely.
N-Linked glycosylation of nascent glycoproteins is tem-
porally coupled to the protein translocation reaction that
occurs as, or immediately after, the polypeptide is synthe-
sized. The coordination of N-linked glycosylation and pro-
tein translocation necessitates a spatial localization of the
OST adjacent to the protein translocation channel. Even
though the OST has unrestricted access to nascent polypep-
tides entering the ER lumen, a surprising percentage of con-
sensus glycosylation sites are not modified in vivo. Here, we
review the effect of acceptor peptide sequence as well as
sequence context factors that influence N-linked glycosyla-
tion of N-X-T/S sites in vivo and in vitro.
The elucidation of the roles of the noncatalytic OST sub-
units remains an important issue. In this article, we review
the biochemical and genetic characterization of the yeast
and mammalian OST subunits, in the context of emerging
information about the evolution of the OST that is being
deduced from genomics data. Potential roles for several
subunits can now be proposed based upon the available
data and upon the differences in the enzymatic properties
of the OST in diverse organisms.
Ancient origin of N-linked glycosylation
N-Linked glycosylation of proteins was initially thought to
be restricted to eukaryotic organisms. The first evidence
that this was not the case came from the structural analysis
of alkali-insensitive glycopeptides derived from Halobacte-
rium cell surface glycoprotein (CSG) and flagellins (for a
review, see Lechner and Wieland, 1989). These Halobacte-
rium salinarum proteins are modified with tetrasaccharides
composed of glucose and sulfated glucuronic and iduronic
acids that are linked to asparagine residues through glucose
(Wieland et al., 1983, 1985). The glycosylated asparagines
are in an N-X-T/S motif that matches the sequon for
N-linked glycosylation in eukaryotic organisms (Wieland
et al., 1985). Furthermore, a dolichol-phosphate-linked
tetrasaccharide serves as the oligosaccharide donor for
N-linked glycosylation in H. salinarum (Lechner et al.,
1To whom correspondence should be addressed; e-mail: 
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1985). A second glycosaminoglycan-like oligosaccharide is
attached to the H. salinarum CSG through an asparaginyl-
N-acetylgalactosamine linkage at an N-A-S site (Paul et al.,
1986) using a dolichol-pyrophosphate-linked oligosaccha-
ride as a donor (Lechner and Wieland, 1989). In contrast to
what we know about the acceptor-substrate specificity for
the eukaryotic OST, addition of the glycosaminoglycan-
like oligosaccharide to CSG still occurred when the serine
in the N-A-S sequon was replaced with a valine or leucine
residue (Zeitler et al., 1998). Thus, in H. salinarum, two
structurally different N-linked oligosaccharides are attached
to N-X-S/T sites by what are likely distinct enzymes based
upon differences in donor substrate structure and acceptor
substrate specificity. The flagellins of Methanococcus voltae
are N-glycosylated at multiple N-X-T/S sites with a trisac-
charide through an asparaginyl-β-GlcNAc linkage (Voisin
et al., 2005). The most abundant oligosaccharide donor in
Haloferax volcanii is mannosyl-(β1–4)galactosyl phospho-
dolichol (Kuntz et al., 1997). Taken together, it appears
that donor substrates for N-glycosylation in archaebacte-
rial organisms are structurally diverse, yet are assembled
upon dolichol phosphate or dolichol pyrophosphate carriers.
Recent evidence indicates that several eubacteria, includ-
ing Campylobacter jejuni, have acquired a 14-gene pgl (pro-
tein glycosylation) operon that is involved in N-linked
glycosylation of cell surface proteins. Protein sequence
analysis of the pgl operon (Szymanski et al., 1999) revealed
that PglB is homologous to the STT3 subunit of the
eukaryotic OST. Mutagenesis of the pglB locus and chemi-
cal deglycosylation of C. jejuni membrane proteins led to
the conclusion that the pgl operon is involved in protein
glycosylation (Szymanski et al., 1999). We refer the reader
to a recent review of eubacterial glycosylation for more
information concerning the roles of the pgl gene products in
the assembly pathway of the undecaprenyl-pyrophosphate-
linked oligosaccharide donor for N-linked glycosylation in
eubacteria (Szymanski and Wren, 2005).
Oligosaccharide donors for the eukaryotic OST
In eukaryotic organisms, the oligosaccharide donor for
N-linked glycosylation of proteins is assembled on the car-
rier lipid dolichol pyrophosphate by the sequential addition
of the monosaccharides GlcNAc, Man, and Glc (Figure 1).
Chemically synthesized donor substrate analogues that
replace dolichol-PP with phytanyl-PP, dihydrofarnesyl-PP,
or citronellyl-PP are not substrates for the OST (Fang
et al., 1995), but polyprenol-PP-linked oligosaccharides are
utilized as donors in the Chinese hamster ovary cell line
B211 (Kaiden et al., 1998).
The assembly pathway for Glc3Man9GlcNAc2-PP-Dol
has been deduced from the analysis of intermediates that
accumulate in vitro in membranes from wild-type cells
(Chapman et al., 1979; Liu et al., 1979) and by the analysis of
the yeast alg mutants that lack glycosyltransferase activities
(Huffaker and Robbins, 1983; Burda and Aebi, 1999). Most
of the glycosyltransferases (ALG proteins) that mediate
Glc3Man9GlcNAc2-PP-Dol assembly have now been identified
(Figure 1). OS-PP-Dol assembly initiates on the cytoplasmic
face of the RER, where sugar nucleotides (UDP-GlcNAc
and GDP-Man) serve as the saccharide donors for the
addition of the first seven residues (Figure 1, red symbols) to
yield Man5GlcNAc2-PP-Dol. The initial step in OS-PP-Dol
assembly is catalyzed by N-acetylglucosaminyl phosphate
transferase (ALG7) that forms the phosphodiester linkage
between GlcNAc-1-phosphate (derived from UDP-GlcNAc)
and dolichol-monophosphate.
Fig. 1. The structure and assembly pathway for eukaryotic dolichol-
linked oligosaccharides. GlcNAc residues are designated by circles, 
mannose residues by squares, and glucose residues by triangles. Numbers 
within saccharide units designate the order of saccharide addition. Red 
residues are transferred to the dolichol-pyrophosphate carrier on the 
cytoplasmic face of the RER, blue residues are added on the lumenal side. 
The yeast gene(s) that encodes each glycosyltransferase is indicated if 
known. Currently described subtypes of CDG-1 are identified by the step 
in OS-PP-Dol assembly that is affected. The role of Alg11p in transfer of 
residue 7 is uncertain at this time.
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The most recently identified glycosyltransferase in the
OS-PP-Dol assembly pathway is the ALG13–14 het-
erodimer that mediates the addition of the second GlcNAc
residue to form Dol-PP-GlcNAc2 (Bickel et al., 2005;
Chantret et al., 2005; Gao et al., 2005). Dol-PP-GlcNAc2 is
the in vivo oligosaccharide donor for N-linked glycosyla-
tion in Giardia lamblia (Samuelson et al., 2005). The yeast
or vertebrate OST will utilize Dol-PP-GlcNAc2 as a donor
substrate in an in vitro assay (Sharma et al., 1981; Imperiali
and Shannon, 1991). The importance of the two N-acetyl
moieties in Dol-PP-GlcNAc2 has been investigated using
several synthetic dolichol-linked oligosaccharides (Tai and
Imperiali, 2001). Dol-PP-GlcNAc-Glc, like the minimal in
vivo donor Dol-PP-GlcNAc2, is a functional donor for the
OST, indicating that the 2´-N-acetyl modification of the
second sugar is not critical for OST recognition and catalysis.
Although glycopeptide products bearing a single GlcNAc
were detected by mass spectroscopy when Dol-PP-GlcNAc
was tested as the donor, Dol-PP-GlcNAc is clearly a very
poor donor substrate for the OST (Bause et al., 1995; Tai and
Imperiali, 2001). Dol-PP-2-deoxyfluoroglucose-GlcNAc and
Dol-PP-N-trifluoroacetylglucosamine-GlcNAc are not sub-
strates but are instead OST inhibitors. These results demon-
strate that the N-acetyl modification on the proximal sugar
is critical for OST catalysis, whereas the presence and struc-
ture of a second sugar residue (GlcNAc > Glc > no sugar)
increases enzyme activity (Tai and Imperiali, 2001).
Until recently, it was not clear whether Alg2 transfers
residue 4 (an α-1,3 linked mannose) or residue 5 (an α-1,6
linked mannose). Analysis of human ALG2 mutant fibro-
blasts (congenital disorders of glycosylation-Ii [CDG-Ii])
demonstrated that Alg2 is an α-1,3 mannosyltransferase
(Thiel et al., 2003), which provides the substrate for addi-
tion of residue 5 by a currently unidentified mannosyltrans-
ferase (Figure 1). Man3GlcNAc2-PP-Dol accumulates as a
major lipid-linked oligosaccharide in yeast alg11Δ cells pro-
viding evidence that Alg11p is an α-1,2 mannosyltrans-
ferase responsible for the addition of residue 6 (Helenius
et al., 2002). Although structural analysis of the protein-
linked oligosaccharides synthesized by alg11Δ cells had sug-
gested that Alg11p adds residue 7 (Cipollo et al., 2001), the
latter analysis is complicated by elongation of the alg11Δ
assembly intermediate by lumenal mannosyltransferases.
Given that both residues 6 and 7 are α-1,2 linked mannose,
we speculate that a single enzyme (Alg11p) acts sequentially
to mediate both additions. Support for this hypothesis is
provided by the absence of a candidate GDP-Man-depen-
dent mannosyltransferase of unknown function encoded by
the yeast genome. Man5GlcNAc2-PP-Dol is then flipped
from the cytoplasmic face of the ER into the lumen in a
reaction that is dependent upon Rft1 in vivo (Helenius
et al., 2002).
The dolichol monosaccharides Dol-P-Man and Dol-P-Glc
serve as the sugar donors for the three lumenal mannosyl-
transferases (ALG3, ALG12, and ALG9) and three glucosyl-
transferases (ALG6, ALG8, and ALG10) that sequentially
transfer residues 8–14 onto the OS-PP-Dol (Figure 1).
The ordered addition of the sugar residues is maintained by
the remarkable substrate specificity of the glycosyltransferases.
For example, the predominant OS-PP-Dol compound synthe-
sized by the alg3Δ yeast mutant is Man5GlcNAc2-PP-Dol not
Glc3Man5GlcNAc2-PP-Dol or Glc3Man7GlcNAc2-PP-Dol
(Verostek et al., 1993; Aebi et al., 1996; Kelleher et al., 2001)
indicating that Man5GlcNAc2-PP-Dol is a poor substrate for
the Alg6 and Alg12 enzymes. Additional insight into this step-
wise assembly pathway has been provided by the discovery that
Alg9 transfers two α-1,2-linked mannose residues (Figure 1,
residues 9 and 11). The first addition yields the Man7GlcNAc2-
PP-Dol intermediate (Burda et al., 1996; Cipollo and Trimble,
2000) that is the substrate for Alg12. Alg9 then adds the ninth
and final mannose residue to oligosaccharide donor (Frank and
Aebi, 2005).
Defects in donor assembly are responsible for CDG-I
OS-PP-Dols lacking the terminal glucose residue are less effec-
tive donors for the vertebrate and yeast OST both in vitro and
in vivo (Turco et al., 1977; Trimble et al., 1980; Burda and
Aebi, 1998; Karaoglu et al., 2001). Enzymatic defects that
interfere with the biosynthesis of Glc3Man9GlcNAc2-PP-Dol
are responsible for a family of diseases referred to as CDG-I
(for a recent review of CDG, see Freeze and Aebi, 2005).
Reductions in phosphomannose isomerase activity (PMI;
CDG-Ib), phosphomannomutase activity (PMM, CDG-
Ia), and Dol-P-Man synthase activity (CDG-Ie) reduce the
biosynthesis of the mannose donors (GDP-mannose and
Dol-P-Man), thereby causing an accumulation of diverse
assembly intermediates (as reviewed in Aebi and Hennet,
2001). The role of the vertebrate LEC35 gene product in
OS-PP-Dol assembly was unclear as Lec35 mutants accu-
mulate Man5GlcNAc2-PP-Dol (Lehrman and Zeng, 1989)
but are not defective in Alg3 activity and have normal levels
of Dol-P-Man. Lec35 cells were recently shown to be defec-
tive in all aspects of Dol-P-Man and Dol-P-Glc utilization
(Anand et al., 2001), hence the LEC35 gene product is now
referred to as mannose-P-dolichol utilization (MPDU).
Deficiencies in human MPDU are responsible for CDG-If
(Kranz et al., 2001; Schenk et al., 2001).
Several recently identified CDG-I subtypes (Figure 1,
subtypes Ig, Ih, and Il) cause the accumulation of an OS-
PP-Dol assembly intermediate that is a poor substrate for
the OST (Chantret et al., 2002; Frank et al., 2004; Schollen
et al., 2004). CDG-Ij, Ik, and Ii are caused by mutations
that reduce the activity of early acting glycosyltransferases
(ALG7, ALG1, and ALG2), thereby reducing the steady-
state pool of Glc3Man9GlcNAc2-PP-Dol that can serve as
the oligosaccharide donor (Thiel et al., 2003; Wu et al.,
2003; Grubenmann et al., 2004).
Acceptor substrates and peptide inhibitors of the OST
Sequencing of N-glycopeptides derived from eukaryotic
glycoproteins established that N-glycosylated asparagine
residues are within an N-X-T/S consensus sequon, where X
can be any residue except proline (Marshall, 1972). Pro-
vided that the N- and C-termini are blocked by reagents
that mimic peptide bonds, N-X-T tripeptides are glycosylated
by the OST in vitro (Welply et al., 1983). N-Glycosylated
N-X-C sites are present in human von Willebrand factor
and serum protein C (Titani et al., 1986; Miletich and Broze,
D.J. Kelleher and R. Gilmore 
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1990). In vitro assays using synthetic peptide substrates with
internal N-X-T/S/C sites showed that the kinetic parame-
ters of the OST (peptide Km and Vmax) are strongly influ-
enced by the side chain in the +2 position relative to
asparagine, with N-X-T serving as a better substrate than
N-X-S, which is in turn much better than N-X-C (Bause,
1984; Breuer et al., 2001). Peptides containing asparagine
analogues have been tested as potential OST substrates and
inhibitors. As expected from the sequence of natural glyco-
peptides, the sequon analogues Q-X-T and D-X-T are nei-
ther substrates nor high-affinity inhibitors (Welply et al.,
1983; Bause et al., 1995). Of more than a dozen tested pep-
tides wherein asparagine is replaced by an amino acid ana-
logue (Welply et al., 1983; Bause et al., 1995; Xu T., Werner
M., et al., 1998), β-hydroxyasparagine was found to yield a
low affinity substrate, whereas diaminobutanoic acid
(Amb) yielded a promising lead compound for OST inhibi-
tors (Bause et al., 1995), as discussed below.
The yeast and vertebrate OST have a surprisingly low
affinity (Kp ∼ 10–30 μM) for a synthetic tripeptide substrate
(e.g., N-Ac-N-[125I]Y-T-NH2; Karaoglu et al., 2001; Kelleher
et al., 2003). Hydrophobic N-terminal blocking groups
(N-benzoyl and N-octanoyl) enhance peptide-binding affin-
ity relative to an N-acetyl blocking group, whereas bulky
N-terminal blocking groups (N-t-butoxycarbonyl or N-4-
benzoyl-benzoyl) reduce peptide-binding affinity (Welply
et al., 1983; Xu T., Khanna H., et al., 1998). Taken together
with the effect of X-residue substitutions within an N-X-S
sequon (Shakin-Eshleman et al., 1996), these observa-
tions indicate that residues other than asparagine and the
hydroxy amino acid (S or T) can facilitate acceptor-
substrate binding to the OST active site.
Two strategies have been used to obtain high-affinity
substrates and more potent OST inhibitors. Conformation-
ally constrained peptides that adopt β-turn or asparagine-
turn conformations have been tested as OST substrates,
and it was found that peptides that adopt the latter, but not
former, conformation are OST substrates (Imperiali et al.,
1992). Cyclization of synthetic OST substrates has been
achieved by covalently linking an N-terminal blocking
group on asparagine to the cysteine side chain in a N-C-T
sequon to obtain the cyclo(hex-Asn-Cys)-Thr series of sub-
strates or to an Amb-C-T tripeptide to obtain the
cyclo(hex-Amb-Cys)-Thr series of OST inhibitors (Hen-
drickson et al., 1996; Kellenberger et al., 1997). Peptide
cyclization appears to cause a relatively modest increase in
the binding affinity relative to noncyclic-control peptides
that have a hydrophobic, N-terminal blocking group
(Kellenberger et al., 1997; Peluso et al., 2002). In contrast, a
dramatic increase in the binding affinity (Ki < 50 nM) of
OST inhibitors has been achieved by extending the C-
terminus of the peptides by several residues to obtain
cyclo(hex-Amb-Cys)-Thr-Val-Thr-Nph-NH2, where Nph
corresponds to para-nitrophenylalanine (Hendrickson et al.,
1996). Peptide extensions that included one or more
charged amino acids (e.g., K-K-Nph-NH2, E-K-Nph-NH2,
or V-E-Nph-NH2) yielded markedly less-effective inhibitors
or substrates (Kellenberger et al., 1997). The design of the
Val-Thr-Nph-NH2 extension was based upon a careful reex-
amination (Imperiali and colleagues) of the statistical fre-
quency of amino acids at the +3 and +4 residues adjacent to
utilized and nonutilized N-X-T sites (Gavel and Von
Heijne, 1990).
Context factors that influence N-linked glycosylation 
of sequons
It has been estimated that ∼35% of the potential glycosyla-
tion sites in proteins that enter the ER lumen are not modi-
fied (Petrescu et al., 2004), and others are modified with low
efficiency. Sequence analysis of a large collection of utilized
and nonutilized N-X-T/S sites in proteins that enter the
secretory pathway showed that a proline residue in the +3
site relative to asparagine reduces the statistical frequency of
N-glycosylation (Gavel and Von Heijne, 1990). Hexapep-
tides with internal N-P-T sites or N-X-T-P sites are neither
substrates nor low-affinity inhibitors (Bause, 1983). The sta-
tistical analysis of utilized N-glycosylation sites also supports
the preference for N-X-T sites relative to N-X-S sites (Gavel
and Von Heijne, 1990). The influence of amino acids in the X
position of N-X-T and N-X-S sites has been tested in the
context of the rabies virus glycoprotein. Although the iden-
tity of the X-residue had little effect upon the glycosylation
efficiency of N-X-T sites, several residues (Glu, Asp, Trp,
and Leu) significantly reduced the glycosylation efficiency of
N-X-S sites (Shakin-Eshleman et al., 1996). Analysis of sev-
eral proteins with overlapping sequons (N-N-T/S-T/S) has
shown that a single glycan is attached to such a site (Lock-
ridge et al., 1987; Reddy et al., 1988, 1999). Recent results
support the conclusion that an N-linked glycan at an aspar-
agine residue reduces access of a closely spaced sequon to the
OST active site (Karamyshev et al., 2005).
Potential glycosylation sites that are located <12–14
residues from a transmembrane (TM) span are not uti-
lized by the vertebrate OST, indicating that the OST
active site is ∼30–40 Å above the lumenal membrane sur-
face of the RER (Nilsson and von Heijne, 1993). Not only
does this distance restraint on glycosylation of membrane
proximal N-X-T/S sites explain a lack of glycosylation of
some integral membrane proteins, it is relevant to the gly-
cosylation scanning mutagenesis procedure that has been
used to elucidate the topology of membrane proteins
(Hresko et al., 1994). Sequons inserted into short lumenal
loops are not glycosylated (Popov et al., 1997). Glycosyla-
tion sites near the C-terminus of proteins are also less
likely to be utilized (Gavel and Von Heijne, 1990), pre-
sumably because chain termination allows the protein to
move more rapidly past the OST active site. Glycosylation
of N-X-T/S sites can also be reduced by a disulfide bond
involving a nearby cysteine residue (Allen et al., 1995) or
delayed or inhibited if the N-X-T/S site is near the signal
peptidase cleavage site (Chen et al., 2001). Mutations that
prevent folding of a glycoprotein may be accompanied by
N-glycosylation at sequons that are not normally modi-
fied (McGinnes and Morrison, 1994), indicating that
rapid protein folding may be responsible for inefficient
modification of some N-X-T/S sites. A detailed analysis of
the extent of glycosylation at each of the 14 sites in yeast
invertase suggests that additional sequence context factors
may influence the efficiency of modification of individual
glycosylation sites (Reddy et al., 1988).
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Subunit composition of the OST in eukaryotic organisms
The OST has been most extensively investigated in the yeast
(Saccharomyces cerevisiae) and vertebrate (canine pancreas)
experimental systems. A combination of protein biochemis-
try and yeast molecular genetics experiments has led to the
identification of eight polypeptides (Figure 2A) that are
assembled into a heterooctameric yeast OST complex com-
posed of one copy each of Ost1p, Ost2p, Ost3p or Ost6p,
Ost4p, Ost5p, Wbp1p, Swp1p, and Stt3p (Karaoglu et al.,
1997; Spirig et al., 1997). Although several papers describe
yeast OST complexes that apparently lack 2–4 of the above
subunits (Kelleher and Gilmore, 1994; Knauer and Lehle,
1994; Pathak and Imperiali, 1997), this discrepancy is
explained by the difficulty in detecting the diffusely migrating
Stt3 protein as well as the three low molecular weight sub-
units (Ost2p, Ost4p, and Ost5p) on sodium dodecyl sulfate
(SDS)-polyacrylamide gels (Karaoglu et al., 1997). Protein
sequence database searches and protein purification results
indicate that the yeast and vertebrate OST complexes have
very similar subunit compositions (Kelleher and Gilmore,
1997; Kelleher et al., 2003). Canine OST complexes com-
posed of ribophorin I (Ost1p), ribophorin II (Swp1p), OST48
(Wbp1p), DAD1 (Ost2p), and an STT3 homologue have
been purified from canine pancreas (Kelleher et al., 2003).
Below, the subunits of the OST are discussed in their approx-
imate order of discovery.
Wbp1 (OST48)
The Wbp1 protein (OST48 in vertebrates) was the first identi-
fied subunit of the yeast OST (te Heesen et al., 1992) and one
of the first three identified subunits (ribophorin I, ribophorin
II, and OST48) of the purified canine OST (Kelleher et al.,
1992; Silberstein et al., 1992). Wbp1 (OST48) proteins have an
N-terminal signal sequence that is cleaved in vivo (te Heesen
et al., 1991; Silberstein et al., 1992), N-linked glycans (yeast
Wbp1 but not canine OST48), a hydrophobic segment near
the C-terminus that serves as a TM span, and a short cytoplas-
mic tail that has a C-terminal dilysine ER retention/retrieval
motif (Gaynor et al., 1994; Fu and Kreibich, 2000). These
sequence features demonstrated that Wbp1 is a type I (Nlum-
Ccyt) integral membrane protein with a large lumenal domain
(Figure 2A). Wbp1 proteins are encoded by genomes from
diverse eukaryotes including vertebrates, fungi, nematodes,
arthropods, plants, Dictyostelium discoideum, and many, but
not all protists (Figure 2A–D), and show little variation in
polypeptide length between organisms. Protein sequence com-
parisons suggest that Wbp1 proteins are members of the
GldG/intraflagellar transport (GIFT) domain protein family
that includes diverse prokaryotic and eukaryotic proteins
(Beatson and Ponting, 2004). As the X-ray structure of a
GIFT domain has not been solved, the biological function and
structure of this domain in the Wbp1 proteins is not known.
Point mutations in Wbp1 reduce in vivo and in vitro OST
activity (te Heesen et al., 1992) and destabilize the OST com-
plex (Karaoglu et al., 1997). Deletion of the Wbp1 TM span or
replacement of this segment with other hydrophobic
sequences is not tolerated because of lack of incorporation of
these mutant proteins into the OST complex (Li et al., 2003).
Two papers that predated the identification of STT3 as the
active-site subunit suggested that Wbp1/OST48 provides the
oligosaccharide donor and acceptor binding sites that are criti-
cal for enzyme activity. Covalent inactivation of the yeast OST
with a sulfhydryl reagent can be blocked by the presence of
Dol-PP-GlcNAc2, indicating that a cysteine residue, which
was mapped to Wbp1, is located in the dolichol-oligosaccharide
Fig. 2. The OST complex in diverse eukaryotes. The lumenal side of the 
ER membrane is at the top of each panel. The experimentally verified or 
predicted topologies for each subunit are shown. A black curved arrow 
designates a cleaved N-terminal signal sequence; colored arrowheads 
designate the N-termini of proteins that lack cleaved signal sequences. 
The OST subunits are color coded to designate the three putative 
subcomplexes (blue for Ost1-Ost5, red for Swp1-Wbp1-Ost2, green for 
Stt3-Ost3-Ost4) and are drawn to scale. Yellow lines in panels A–D desig-
nate N-terminal (ribophorin II) or C-terminal (ribophorin I) extensions 
that are present/predicted as indicated by the labeled arrows. (A) The sub-
unit composition of the fungal (Saccharomyces cerevisiae) and vertebrate 
(Canis familiaris) OST complexes are based upon biochemical and genetic 
evidence summarized in the text. Predicted subunit compositions for 
organisms other than Saccharomyces cerevisiae and Canis familiaris (A–E) 
are based upon protein and DNA sequence database searches using 
Saccharomyces cerevisiae and human OST sequences as the query sequence. 
(A) Predicted OST complexes for other fungi (Schizosaccharomyces 
pombe, Cryptococcus neoformans, and Aspergillus nidulans) and verte-
brates (Homo sapiens and Mus musculus) have seven or eight subunits (see 
text). (B) Predicted OST complexes for insects (Drosophila melanogaster 
and Anopheles gambiae), plants (Arabidopsis thaliana and Oryza sativa), 
nematodes (Caenorhabdilis elegans), Dictyostelium discoideum, and 
Tetrahymena thermophila have seven subunits. OST complexes from 
protists are predicted to have six subunits (C, Cryptosporidium parvum), 
four subunits (D, Entamoeba histolytica, Trichomonas vaginalis, and 
Plasmodium falciparum) or a single subunit (E, Giardia lamblia, 
Trypanosoma cruzi, and Trypanosoma brucei).
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binding site of the OST (Pathak et al., 1995). The significance
of this result cannot be discounted given that enzyme kinetic
experiments now suggest that the OST has two independent
OS-PP-Dol binding sites (Karaoglu et al., 2001). OST48 and a
68-kDa protein (thought to be ribophorin I at the time, but
probably STT3A instead) were labeled with a suicide substrate
analogue, wherein the hydroxy amino acid (T or S) was
replaced by epoxyethylglycine (Bause et al., 1997).
Ost1 (ribophorin I)
The Ost1/ribophorin I subunit is present in the purified
yeast and vertebrate OST complexes. The yeast OST1 gene
was isolated based upon peptide sequence data (Silberstein
S., Collins P.G., Kelleher D.J., Rapiejko P.J., et al., 1995)
and identified in a genetic screen for mutations that reduce
OST activity (Reiss et al., 1997). The Ost1 proteins have an
N-terminal signal sequence that is cleaved in vivo, N-X-T/
S sites that carry N-linked glycans in yeast and vertebrates,
a single TM span and a C-terminal cytosolic domain,
hence Ost1 proteins have a type I (Nlum-Ccyt) topology
(Crimaudo et al., 1987; Silberstein S., Collins P.G., Kelleher
D.J., Rapiejko P.J., et al., 1995). Protein sequence data-
base searches reveal that Ost1/ribophorin I orthologues are
encoded by all fully sequenced eukaryotic genomes except
Encephalitozoon cuniculi, G. lamblia, and the kinetoplastids
(Figure 2A–D). The cytoplasmic domains of Ost1/ribo-
phorin I proteins are either <10 residues in length (fungi,
insects, and many protists) or 140–160 residues in length
(vertebrates, plants, nematodes, and Plasmodium). Con-
sensus protein secondary structure prediction algorithms
(http://npsa-pbil.ibcp.fr/.) indicate that the longer cyto-
plasmic tails have a high probability of being α-helical.
Point mutations in Ost1 reduce N-linked glycosylation in
vivo and reduce in vitro OST activity (Silberstein S., Collins
P.G., Kelleher D.J., Rapiejko P.J., et al., 1995). Labeling of
Ost1 with photoreactive acceptor substrates was detected
using an immunoprecipitation strategy (Yan et al., 1999).
However, subsequent studies did not support the initial
conclusion that Ost1 was the active site subunit.
Ribophorins I and II are abundant proteins of the mam-
malian RER (Kreibich et al., 1978) that are present in
roughly equal amounts relative to membrane-bound ribo-
somes (Marcantonio et al., 1984). Antibodies raised against
the cytoplasmic domain of ribophorin I interfere with protein
translocation across the RER by preventing ribosome target-
ing to the Sec61 complex (Yu et al., 1990), thereby indicating
that the OST is adjacent to the protein translocation channel.
The location of OST adjacent to the translocon allows the
cotranslational modification of the nascent polypeptide as it
enters the lumen of the RER (Chen et al., 1995).
Swp1 (ribophorin II)
The yeast SWP1 gene was isolated as a high-copy suppressor
of a wbp1 mutant (te Heesen et al., 1993), and Swp1 (ribo-
phorin II) is present in the purified yeast and canine OST
complexes. The Swp1 proteins have an N-terminal signal
sequence that is cleaved in vivo, an N-glycosylation sequon
that is modified in ribophorin II, and three hydrophobic seg-
ments located near the C-terminus (Rosenfeld et al., 1984;
Crimaudo et al., 1987; te Heesen et al., 1993; Kelleher and
Gilmore, 1994). Protease digestion experiments have shown
that C-terminus of ribophorin II is insensitive to protease
digestion in intact microsomes (Crimaudo et al., 1987)
consistent with a three TM (Nlum-Ccyt) topology depicted
in Figure 2A. Swp1/ribophorin II proteins are only
encoded by a subset of eukaryotic genomes (Figure 2A
and B) suggesting that this subunit was a relatively late
addition to the OST complex. Nematode and fungi
genomes encode truncated forms of Swp1/ribophorin II
that lack an N-terminal domain that is predicted to be α-
helical. RNAi of Caenorhabditis elegans ribophorin II
causes an embryonic lethal phenotype (Fraser et al., 2000)
consistent with the previous demonstration that Swp1 is
essential in yeast (te Heesen et al., 1993).
Ost2 (DAD1)
Ost2 was initially detected as a 16-kD subunit in the purified
yeast OST complex (Kelleher and Gilmore, 1994) and was sub-
sequently shown to be present in the mammalian OST com-
plex (Kelleher and Gilmore, 1997) using antibodies specific for
the vertebrate homologue DAD1 (Nakashima et al., 1993).
Ost2 (DAD1) subunits are low molecular weight (112–130 res-
idues) proteins that consist of a polar N-terminal segment of
variable length, followed by three conserved hydrophobic seg-
ments. Protease accessibility experiments have shown that the
N-terminus and the hydrophilic segment between TM2 and
TM3 are exposed on the cytoplasmic face of the membrane
(Silberstein S., Collins P.G., Kelleher D.J., and Gilmore R.,
1995; Kelleher and Gilmore, 1997), consistent with the 3-TM
(Ncyt-Clum) topology model shown in Figure 2A. An alterna-
tive topology model for Ost2p that depicts a 3-TM span pro-
tein with an inverted topology (Yan et al., 2003) is
incompatible with the protease accessibility data cited above
and is not in agreement with an Ost2p-reporter gene fusion
experiment that suggests that the C-terminus is located within
the RER lumen (Yan et al., 2005). An alternative 2-TM
(Ncyt-Ccyt) span model for DAD1 (Makishima et al., 1997) is
based upon the assumption that the third hydrophobic segment
is too polar to be integrated into the membrane. We would
argue that TM3 of Ost2/DAD1 contacts the TM spans of other
OST subunits, rather than phospholipid when Ost2/DAD is
assembled into the OST complex. Ost2/DAD1 proteins are
encoded by all fully sequenced eukaryotic genomes except E.
cuniculi, G. lamblia, and the kinetoplastids (Figure 2A–D).
Point mutations in the TM spans of Ost2 cause in vivo
and in vitro reductions in OST activity at the restrictive
temperature (Silberstein S., Collins P.G., Kelleher D.J.,
and Gilmore R., 1995). A temperature sensitive mutation
in the hamster DAD1 (defender against death) protein
causes an apoptotic phenotype in the tsBN7 cell line
because of instability of DAD1 (Nakashima et al., 1993).
Degradation of DAD1 at the restrictive temperature
results in a severe defect in OST activity (Makishima
et al., 1997; Sanjay et al., 1998). The apoptotic phenotype
of tsBN7 cells is most likely because of the irreversible
induction of the unfolded protein response (UPR) path-
way caused by the accumulation of unfolded glycopro-
teins, as tunicamycin can also induce apoptosis in plant
and vertebrate cell lines (Pérez-Salva and Mollinedo,
1995; Walker et al., 1998; Iwata and Koizumi, 2005).
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STT3
Mutations in the yeast STT3 locus were isolated in a screen
for yeast that showed enhanced sensitivity to staurosporine
(Yoshida et al., 1992), an inhibitor of protein kinase C. Addi-
tional stt3 alleles were obtained in genetic screens for muta-
tions that confer a synthetic lethality phenotype when
combined with the wbp1-2 allele (Zufferey et al., 1995) or the
alg5Δ allele (Reiss et al., 1997). Because the yeast STT3 gene
encodes a 78-kDa protein that was not detected in the puri-
fied yeast OST complex (Kelleher and Gilmore, 1994; Knauer
and Lehle, 1994; Pathak and Imperiali, 1997), it was initially
unclear whether Stt3 was an OST subunit (Yoshida et al.,
1995; Zufferey et al., 1995). Subsequent immunopurification
experiments using yeast strains that express affinity-tagged
OST subunits (STT3-HA, STT3-protein A, or OST3-HA)
demonstrated that Stt3 is in an equimolar complex with the
other OST subunits (Karaoglu et al., 1997; Spirig et al., 1997).
The topology of the Stt3 proteins is more difficult to pre-
dict and experimentally verify than any of the other OST
subunits. Eukaryotic Stt3 proteins consist of an N-terminal
hydrophobic domain composed of 12–13 predicted TM
spans followed by a C-terminal hydrophilic domain that is
located within the RER lumen (Zufferey et al., 1995). The
N-termini of canine STT3A and yeast Stt3 is exposed to the
cytosol, hence eukaryotic STT3 proteins must have an
uneven number of TM spans (e.g., 11 or 13) and a Ncyt-
Clum topology (Kelleher et al., 2003; Kim et al., 2005).
STT3 topology models with 13 TM spans (as depicted in
Figure 2) are based on the assumption that each of the 13
hydrophobic segments are bona fide TM spans, whereas 11
TM span models necessitate that two of the hydrophobic
segments are instead exposed on the cytosolic or lumenal
faces of the membrane. A comprehensive investigation of
the topology of the yeast and mouse STT3 proteins pro-
vided support for two conflicting 11 TM span models (Kim
et al., 2005), suggesting that structural biology data will be
needed to define the topology of the Stt3 proteins.
As initially suggested by the alignment of STT3 protein
sequences from S. cerevisiae, C. elegans, and Mus musculus
(Zufferey et al., 1995), the Stt3 subunit is the most highly con-
served polypeptide in the OST complex. With the exception of
E. cuniculi, which lacks N-linked glycosylation, all fully
sequenced eukaryotic genomes encode at least one member of
the Stt3 protein family (Figures 2 and 3). Vertebrate, plant,
and insect genomes encode two STT3 proteins that we have
designated as STT3A and STT3B (Kelleher et al., 2003).
Vertebrate STT3A was initially named TM conserved (TMC)
(Lissy et al., 1996), whereas STT3B is also known as
source of immunodominant major histocompatibility
complex-associated peptides (SIMP) (McBride et al., 2002).
Phylogenetic tree analysis shows that STT3B proteins are
more closely related to the fungal and nematode STT3 pro-
teins, whereas the STT3A protein cluster includes STT3 from
D. discoideum (Figure 3). Several protist genomes encode mul-
tiple STT3 proteins that reflect gene duplication events that
are unrelated to the derivation of the STT3A and STT3B sub-
families. For example, four consecutive genes on one chromo-
some encode the predicted Leishmania major STT3 proteins.
To our knowledge, it is not known whether multiple STT3
proteins are simultaneously expressed in protist organisms.
Ost3/Ost6 (N33 and IAP)
The Ost3 protein was initially detected as a 34-kD subunit
in the yeast OST complex (Kelleher and Gilmore, 1994).
Ost6p is a homologue of Ost3p that is assembled into a sec-
ond, less abundant, form of the yeast OST complex that
lacks Ost3p as a subunit (Karaoglu et al., 1997; Knauer and
Lehle, 1999; Spirig et al., 2005). The Ost3 family of proteins
have an N-terminal signal sequence that is cleaved in vivo
in yeast, a 160–180 residue N-terminal lumenal domain that
includes one thioredoxin repeat (Fetrow et al., 2001) fol-
lowed by four predicted TM spans (Karaoglu et al., 1995).
Consequently, the Ost3 proteins are integrated into the RER
Fig. 3. Phylogenetic tree analysis of STT3 proteins. STT3 protein 
sequences were obtained by protein and DNA sequence database searches 
(Kelleher et al., 2003; Samuelson et al., 2005) using the Saccharomyces 
cerevisiae Stt3 and human STT3A as query sequences. Representative 
fungal and metazoan STT3 sequences as well as all currently available 
protist sequences were selected for alignment. Several archaebacterial and 
eubacterial STT3 homologues were used to root the phylogenetic tree.
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with a 4-TM (Nlum-Clum) topology (Figure 2A). Recently,
the 4-TM (Nlum-Clum) topology for the Ost3 family has been
disputed based upon results obtained with a reporter–gene
fusion strategy (Yan et al., 2003, 2005). An alternative topol-
ogy model for Ost3 predicts that a very short, weakly hydro-
phobic segment within the thioredoxin motif of Ost3p
functions as a fifth TM span, thereby inverting the topology
of Ost3 to yield a 5-TM (Nlum-Ccyt) topology (Yan et al.,
2003, 2005). Both termini of Ost6 are proposed to face the
cytosol in a 4-TM (Ncyt-Ccyt) topology (Yan et al., 2005),
which would expose the N-terminal signal sequence and the
thioredoxin domain of Ost6 on to the cytoplasmic side of the
membrane (Chavan et al., 2005). How can we explain the
discrepancy between these recent proposals and the previ-
ously accepted topology model shown in Figure 2A?
Although reporter–domain fusions have been used exten-
sively to define the topology of bacterial and vertebrate
membrane proteins, this strategy can be less satisfactory in
yeast (as discussed by Kim H., Melen K., et al., 2003),
because integration of membrane proteins can be perturbed
by an N-terminal fusion joint that inactivates a signal
sequence or by a C-terminal fusion joint that interferes with
integration of the final TM span (Green and Walter, 1992).
Protein sequence database searches show that members of
the Ost3 family of proteins are encoded by all fully
sequenced vertebrate, nematode, fungi (except E. cuniculi),
arthropod, and plant genomes. In addition, Ost3 homo-
logues are encoded by D. discoideum, Tetrahymena thermo-
phila, and Cryptosporidium parvum. The gene duplication
event that is responsible for the OST6 gene is restricted to the
Saccharomycetaceae family of budding yeasts. Phylogenetic
tree analysis using currently available fungal Ost3/Ost6
sequences indicates that other fungal genomes encode a pro-
tein that is more closely related to Ost3 than to Ost6p (not
shown). Vertebrate genomes encode two closely related Ost3
homologues that are annotated as N33 and IAP (MacGro-
gan et al., 1996; Kelleher et al., 2003). Unlike Ost3 and Ost6
that are present in the purified yeast OST complex (Kelleher
and Gilmore, 1994; Karaoglu et al., 1997) and comigrate
with the OST on Blue-Native gels (Knauer and Lehle, 1999),
N33 and IAP appear to be loosely associated with the canine
OST complex and dissociate at various stages during enzyme
purification (Kelleher et al., 2003) or during Blue-Native
polyacrylamide gel electrophoresis (Shibatani et al., 2005).
Disruption of the yeast OST3 or OST6 genes does not
cause a growth defect at any temperature in an otherwise
wild-type strain (Karaoglu et al., 1995; Knauer and Lehle,
1999). Loss of Ost3p expression in yeast causes a modest,
and substrate dependent, reduction in the in vivo glycosyla-
tion of proteins (Karaoglu et al., 1995). The mild phenotypes
of the ost3Δ strain are explained in part by redundancy, as
an ost3Δost6Δ strain has a more severe defect in glycosyla-
tion than either single mutant (Knauer and Lehle, 1999;
Spirig et al., 2005). The C. elegans OST3 gene (ZK686.3) is
essential; RNAi of ZK686.3 causes an embryonic lethal
phenotype (Kamath et al., 2003) because of a defect in
cytokinesis (Gonczy et al., 2000).
Ost4p
The yeast OST4 gene was identified in a screen for yeast
mutants that are resistant to sodium vanadate and sensitive
to hygromycin B (Chi et al., 1996), two properties that are
shared by many yeast mutants that impact different steps in
cell-wall biosynthesis (Dean, 1995). Point mutations, or the
complete deletion, of the nonessential yeast OST4 gene
causes severe in vivo hypoglycosylation of glycoproteins and
a temperature sensitive growth defect (Chi et al., 1996).
Remarkably, the OST4 gene encodes a 36-residue polypep-
tide (Chi et al., 1996), which is one of the smallest verified
proteins encoded by the yeast genome. The single TM span
in Ost4p is preceded by acidic residues and followed by basic
residues thus favoring integration in the type I (Nlum-Ccyt)
topology as initially proposed (Karaoglu et al., 1997; Spirig
et al., 1997). Although a type I topology for Ost4p has been
disputed (Kim et al., 2000), a more recent study confirmed
the original prediction (Kim H., Yan Q., et al., 2003).
Homologues of yeast Ost4 are encoded by fungi, verte-
brate, nematode, insect, plant, and several protist genomes
(Figure 2A–C). Relatively few of these OST4 sequences are
currently annotated in protein sequence databases. For
example, the human and mouse expressed sequence tags
(EST) databases contain highly expressed mRNAs that
encode the 37-residue Ost4 homologue shown in Figure 4.
Fig. 4. Alignment of eukaryotic OST4 sequences. OST4 sequences were obtained by protein and DNA sequence database searches using Saccharomyces 
cerevisiae Ost4 as the query sequence. Representative fungal and metazoan OST4 sequences as well as all currently available protist sequences were selected for 
alignment using ClustalW. Regions of homology are boxed, with amino acid identities designated by dark shading. Replacement of hydrophobic residues 
(M18 to I24) in the TM span of Saccharomyces cerevisiae Ost4 with lysine or aspartic acid caused temperature sensitive growth defects and destabilized the 
interaction between Stt3 and Ost4 (asterisks) or destabilized the interaction between Ost4 and Ost3 (asterisks and diamonds) (Kim et al., 2000).
Eukaryotic oligosaccharyltransferase
55R
Ost4 proteins consist of conserved lumenal and TM seg-
ments followed by a poorly conserved cytoplasmic domain
of variable length (Figure 4). Mass spectroscopy of the
purified canine OST complex has shown that a protein with
a mass (4193 Da) consistent with the vertebrate Ost4
sequence is present in the complex (Kelleher and Gilmore,
unpublished data). Hence we are confident that Ost4 is an
OST subunit in diverse eukaryotes (Figure 2A–C).
Ost5
Ost5 was initially detected as a 9-kDa subunit in the yeast
OST complex (Kelleher and Gilmore, 1994). The OST5
gene was identified in a screen for yeast genes that encode
OST subunits (Reiss et al., 1997). Deletion of the yeast
OST5 gene causes a minor defect in the in vivo glycosyla-
tion of yeast proteins and a reduction in OST activity that is
not caused by an altered affinity for donor or acceptor sub-
strates (Reiss et al., 1997). Ost5p is an 86-residue protein
with two-predicted TM spans. The 2-TM Ncyt-Ccyt topol-
ogy that was predicted for Ost5p (Reiss et al., 1997) has
been confirmed (Yan et al., 2005). Although putative Ost5
homologues can be identified in metazoan organisms using
protein sequence database searches (Kelleher and Gilmore,
unpublished results), biochemical evidence that these
polypeptides are OST subunits has not been obtained
(Kelleher et al., 2003; Shibatani et al., 2005).
The STT3 subunit contains the catalytic site of the OST
The five OST subunits (Stt3, Ost1, Ost2, Swp1, and
Wbp1) that are encoded by essential yeast genes were the
logical candidates for the active-site subunit of the OST.
Of these five proteins, only the Stt3 protein has archae-
bacterial homologues (Spirig et al., 1997). Alignment of
eukaryotic and archaebacterial STT3 proteins resulted in
the identification of a short invariant sequence (WWDXG
motif) that is present in all members of the STT3 family
(Spirig et al., 1997; Burda and Aebi, 1999). During the
past several years, overwhelming evidence has been
obtained indicating that Stt3 family proteins catalyze
N-linked glycosylation in eukaryotes, archaebacteria and
in selected eubacteria.
The most direct evidence that Stt3 proteins are the cata-
lytic subunits of the eukaryotic OST was provided by an
elegant in vivo analysis of the C. jejuni pgl operon. N-linked
glycosylation of AcrA, a C. jejuni membrane protein was
dependent upon a wild-type PglB locus (Wacker et al.,
2002). Moreover, the expression of AcrA and the complete
pgl operon in Escherichia coli reconstituted N-linked glyco-
sylation activity in the E. coli host unless point mutations
were introduced into the WWDYG motif in PglB (Wacker
et al., 2002). Genetic analysis of PglB has been facilitated
by the nonessential nature of N-linked glycosylation in
C. jejuni and in the E. coli host system. Structural analysis
of the resulting glycopeptide showed that the modified
asparagine (N*) was present within the peptide DFN*VSK
(Wacker et al., 2002), where the underlined sequence
matches the N-X-T/S sequon for eukaryotic N-linked gly-
copeptides. The N-X-T/S sequence is necessary, but not
sufficient for N-linked glycosylation in C. jejuni, as several
N-X-T/S sites in the AcrA and HisJ glycoproteins are not
modified (Nita-Lazar et al., 2005). However, because 35%
of N-X-T/S sequons are not modified by the eukaryotic
OST, further work will be required to define a minimum
consensus site for PglB. The heptasaccharide (GalNAc-
α1,4-GalNAc-α1,4-(Glcβ1,3)-GalNAc-α1,4-GalNAc-α1,
4-GalNAc-α1,3-Bac) transferred to proteins by the C. jejuni
PglB protein bears little resemblance to the high-mannose
oligosaccharide donor assembled by eukaryotic cells
(Young et al., 2002), except that the saccharide linked to
the undecaprenyl-pyrophosphate carrier is an amino sugar
(i.e., Bac = bacillosamine = 2,4,diacetamido-2,4,6-trideoxy-
glucose). The relaxed donor-substrate specificity for the
eubacterial OST was further demonstrated by the discovery
that structurally diverse oligosaccharides attached to unde-
caprenyl pyrophosphate are utilized when PglB is expressed
in E. coli (Feldman et al., 2005).
Evidence that Stt3 contains the catalytic center of the
yeast OST has been provided by a combination of photola-
beling experiments and site-directed mutagenesis (Yan and
Lennarz, 2002b). Three of the OST subunits (Ost1, Ost3,
and Stt3) can be photolabeled with acceptor peptides that
incorporate a photoreactive benzophenone side chain near
an N-X-T glycosylation site. Mutagenesis of the C-terminal
lumenal domain of yeast Stt3 yielded a collection of assem-
bly defective and assembly competent stt3 mutants that
displayed severe growth defects and dramatically reduced
OST activity. Point mutations in the WWDYG motif of
yeast Stt3p eliminate or dramatically reduce OST activity
(Yan and Lennarz, 2002b).
Highly selective photocross-linking of a nascent
polypeptide to the active site of the canine STT3A has
been achieved by incorporating a photoreactive derivative
of lysine (K*) adjacent to a cryptic glycosylation site (Q-
K*-T instead of N-K*-T) in a nascent chain undergoing
translocation into the RER lumen (Nilsson et al., 2003).
Unlike the photolabeling experiments summarized above
(Yan and Lennarz, 2002b), cross-links between other OST
subunits and the cryptic glycosylation site were not
detected. Photocross-linking of the cryptic glycosylation
site to STT3A occurred when the photoprobe was located
at least 69 residues away from the peptidyl-transferase site
on the ribosome (Nilsson et al., 2003), which correlates
well with the minimal length between the peptidyl-trans-
ferase site and an N-X-T/S that can be glycosylated in a
ribosome-bound nascent polypeptide (Whitley et al.,
1996). These results reinforce the conclusion that the N-X-
T/S sites pass by the OST active site as the nascent
polypeptide emerges from the lumenal face of the protein
translocation channel.
Biochemical evidence that STT3 proteins are the active
site subunits of the OST complex was provided by the
kinetic analysis of canine OST complexes that incorporate
different isoforms of the STT3 subunit (Kelleher et al.,
2003). OST complexes that have an STT3A subunit display
a higher specificity for selecting the fully assembled doli-
chol-linked oligosaccharide donor (Glc3Man9GlcNAc2-PP-
Dol) than OST complexes that contain an STT3B subunit.
These differences in donor-substrate selection are explained
by STT3 isoform-dependent differences in the kinetic
parameters of the OST active site (Kelleher et al., 2003).
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Organization of subunits into the OST complex
Biochemical and genetic evidence for specific protein–protein
interactions between the OST subunits has steadily accu-
mulated during the past decade. In the absence of a high-
resolution OST structure, we consider how these results can
be incorporated into a working model for the eukaryotic
OST complex.
Nearest-neighbor analysis suggest OST subcomplexes
The first evidence for interactions between OST subunits
was provided by the isolation of the SWP1 gene as an
allele-specific high-copy suppressor of the wbp1-2 mutant
(te Heesen et al., 1993). The overexpression of Ost2, like
Swp1, suppresses the temperature sensitive growth defect of
a wbp1-2 strain by stabilizing Wbp1 (Silberstein S., Collins
P.G., Kelleher D.J., and Gilmore R., 1995). Reciprocal
gene product depletion experiments (Knauer and Lehle,
1994), protein cross-linking studies (te Heesen et al., 1993),
and yeast two-hybrid experiments (Fu et al., 1997) indicate
that Swp1 (ribophorin II) interacts directly with and, by so
doing, stabilizes Wbp1 (OST48). Chemical cross-linking
experiments have defined direct interactions between
DAD1, OST48, and ribophorin II (Kelleher and Gilmore,
1997). Ost48 and ribophorin II are unstable when tsBN7
cells (DAD1-ts cell line) are shifted to the restrictive tem-
perature (Sanjay et al., 1998). Reciprocal loss of stability
would be a weak argument for protein interactions between
Wbp1, Swp1, and Ost2, if a given mutation (e.g., wbp1-2)
reduced the stability of all eight OST subunits. However
this does not appear to be the case based upon western blot
analysis of OST subunit content in wbp1-2 and ost2-3
mutants (Silberstein S., Collins P.G., Kelleher D.J., and
Gilmore R., 1995; Karaoglu et al., 1997). These results led
to the proposal that Wbp1, Swp1, and Ost2 are adjacent in
the OST and constitute one of three subcomplexes (Karao-
glu et al., 1997; Spirig et al., 1997).
Several lines of evidence indicate that Ost3 and Ost4
interact directly with Stt3 in a second subcomplex (Figure
2A). The OST3 and OST4 genes are high-copy allele spe-
cific suppressors of several stt3 mutants, and OST3 is a
high-copy suppressor of the temperature sensitive growth
defect of the ost4Δ mutant (Spirig et al., 1997). Biochemical
support for these interactions was provided by the observa-
tion that an Stt3-Ost3-Ost4 heterotrimer is recovered when
an immunopurified OST complex is incubated in a mixed-
detergent micelle (Triton X-100-SDS) wash buffer (Karao-
glu et al., 1997). Coimmunoprecipitation experiments have
shown that Ost3p dissociates from the OST complex in
detergent extracts prepared from an ost4Δ mutant, indicat-
ing that Ost4 stabilizes the association between Ost3 and
Stt3 (Karaoglu et al., 1997). Point mutations that introduce
charged amino acid residues into the C-terminal half of the
Ost4 TM span (Kim et al., 2000; Kim H., Yan Q., et al.,
2003) cause severe growth defects and destabilize interac-
tions between Stt3, Ost3, and Ost4 (Figure 4). The dissocia-
tion of N33 and IAP from canine OST complexes (Kelleher
et al., 2003) and the dissociation of Ost3 in an ost4Δ mutant
(Karaoglu et al., 1997; Kim et al., 2000) is best explained by
a peripheral location for the OST3 proteins in vertebrate
and fungal complexes. Notably, disruption of the yeast
OST3 gene does not destabilize the remaining subunits in
the OST complex (Karaoglu et al., 1997).
Genetic evidence for a third subcomplex (Ost1-Ost5) was
provided by the discovery that the OST5 gene is a high-
copy suppressor of the ost1-5 allele (Reiss et al., 1997).
More recently, chemical cross-linking experiments provide
additional support for the Ost1p–Ost5p interaction (Yan
et al., 2003). The protein–protein interactions summarized
above must be a subset of those that exist within the OST,
as the active enzyme does not readily dissociate into three
stable subcomplexes when exposed to nonionic detergents.
Although recent chemical cross-linking experiments suggest
numerous additional subunit–subunit contacts (Yan et al.,
2003), it should be noted that the analytical methods used
were unable to distinguish between a direct cross-link
between two subunits and an indirect link that is mediated
by an additional subunit.
Assembly of subcomplexes into the OST; what do we learn 
from genomics?
We can now consider the OST subcomplex hypothesis in
light of the predicted diversity of eukaryotic OST com-
plexes. With the exception of the 1-subunit enzymes pre-
dicted for organisms that are at the base of the eukaryotic
phylogenetic tree (Figure 2E), the simplest eukaryotic OST
is predicted to have four subunits (Figure 2D), including
one or more subunits from each of the putative subcom-
plexes. We can infer from this information that Stt3 pro-
vides an interaction surface for the Wbp1-Ost2-Swp1
subcomplex that is not dependent upon Swp1 (Figure 2C
and D). A direct interaction between Ost1 and Stt3, but not
between Ost1 and the Wbp1-Ost2-Swp1 subcomplex, is
suggested by the dissociation of Ost1 from the latter sub-
complex in Stt3 depleted yeast cells (Zufferey et al., 1995).
These considerations suggest that STT3 provides indepen-
dent binding sites for Ost1 and the Wbp1-Ost2 heterodimer
(Figure 2D).
Three of the OST subunits (Ost2, Ost4, and Ost5) are
hydrophobic miniproteins. It is noteworthy that an Ost4
protein is encoded by all fully sequences genomes that
encode an Ost3 protein (Figures 2A–C and 4). This obser-
vation supports the hypothesis that Ost4p is an assembly/
stabilizing factor for the incorporation of an Ost3 family
protein into the complex (Karaoglu et al., 1997; Kim et al.,
2000). The topology and extensive conservation of the TM
spans of Ost2 suggest the following: (i) the essential func-
tion of Ost2 can be mapped to the TM spans in accord with
mutagenesis results (Silberstein S., Collins P.G., Kelleher
D.J., and Gilmore R., 1995) and (ii) Ost2 may stabilize/
mediate an interaction between Stt3 and Wbp1. Likewise,
one can speculate that Ost5 stabilizes the interaction
between Ost1 and Stt3.
Taken together, the genomic evidence indicates that the
three OST subcomplexes are explained, at least in part, by
the stepwise addition of subunits to an STT3 catalytic core
during evolution of the eukaryotic OST. The first proteins
to be added may have been an Ost1 monomer and the
Wbp1-Ost2 heterodimer. Subsequent enlargement of the
OST involved the addition of four peripheral subunits that
were likely added as a heterodimer (Ost3-Ost4) and two
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monomers (Swp1 and Ost5), with the Wbp1-Ost2 het-
erodimer contributing the binding site for Swp1. Although
a recently published interaction map for the yeast enzyme
places Ost1 in the center surrounded by other subunits
(Yan et al., 2005), such a location is incompatible with
protein cross-linking results obtained using the mammalian
experimental system (Kelleher and Gilmore, 1997) and
yeast two hybrid experiments that did not detect interac-
tions between ribophorin I and II (Fu et al., 1997).
Recently, it has been shown that ribophorin I can be cross-
linked to a subset of nascent integral membrane proteins, in
a sequon-independent manner, as the nascent chains exit
the lateral gate of the Sec61 complex, suggesting an exposed
location for Ost1/ribophorin I in the OST complex (Wilson
et al., 2005). Clearly, a better understanding of the protein–
protein interactions within the OST complex will only be
obtained when mid- or high-resolution structures of the
OST complex are solved.
OST isoforms in mammalian cells
STT3A and STT3B are assembled into alternative forms of
the canine OST complex that differ with respect to donor-
substrate selection and specific activity (Kelleher et al.,
2003). Human multiple-tissue northern blots have shown
that both the STT3A and the STT3B mRNAs are widely
expressed in human tissues, and this conclusion is supported
by the human UniGene database. Protein immunoblot
experiments have shown that both STT3 isoforms are
expressed in human fibroblasts and tissue culture cells
(CH12.LX, HEK293, and HeLa cells; Kelleher et al., 2003;
Ruiz-Canada and Gilmore, unpublished data). Nonetheless,
tissue-specific differences in the relative expression of the
STT3 isoforms are readily apparent and may indicate that
the enzymatic properties of the OST are regulated to
respond to glycoprotein flux through the secretory pathway.
Donor-substrate selection by the eukaryotic OST
The terminal glucose residue on the dolichol-linked oli-
gosaccharide strongly influences the rate of oligosaccharide
transfer in vertebrate and fungal organisms (Turco et al.,
1977; Trimble et al., 1980). The accumulation of nonopti-
mal OS-PP-Dol assembly intermediates is responsible for
the reduced rate of oligosaccharide transfer to nascent gly-
coproteins in tissues from CDG-I patients. The utilization of
a lumenally exposed assembly intermediate (Man5GlcNAc2-
PP-Dol to Glc2Man9GlcNAc2-PP-Dol) should have a dele-
terious effect upon higher eukaryotic organisms, because
the structure of a protein-bound oligosaccharide has a pro-
found effect upon the ability of a nascent glycoprotein to
fold correctly and be packaged into vesicles for intracellular
transport or instead to be targeted for ER-associated degra-
dation (ERAD) if folding is not successful (for a review, see
Parodi, 2000; Schrag et al., 2003; Helenius and Aebi, 2004).
The mechanism of oligosaccharide-donor selection has
been investigated for more than two decades using enzyme
kinetics methods (Trimble et al., 1980; Breuer and Bause,
1995; Gibbs and Coward, 1999). The OST catalyzes a
bisubstrate reaction, where both the donor and acceptor
substrates must be present at the same time. The dolichol
pyrophosphate and glycopeptide products are not OST
inhibitors (Gibbs and Coward, 1999; Peluso et al.,
2002). Competition experiments using donor substrate
mixtures have shown that the fully assembled donor
(Glc3Man9GlcNAc2-PP-Dol) is transferred 5–20 times faster
than an assembly intermediate (e.g., Man9GlcNAc2-PP-Dol)
when the OST is assayed using microsomal membranes
(Karaoglu et al., 2001) or a detergent-solubilized enzyme
(Trimble et al., 1980). Contrary to expectations, several early
studies using detergent-solubilized OST showed that the
apparent Km for the donor oligosaccharide was not signifi-
cantly influenced by the terminal glucose residues (Trimble
et al., 1980; Sharma et al., 1981). Although the structure of
the oligosaccharide donor does have an effect upon the
apparent Km for the acceptor substrate (Breuer and Bause,
1995; Gibbs and Coward, 1999), the relatively modest
enhancement in peptide-binding affinity that is observed in
the presence of Glc3Man9GlcNAc2-PP-Dol relative to that
observed with an assembly intermediate cannot by itself
explain the efficiency of donor-substrate selection.
Enzyme kinetic experiments using purified yeast (Karao-
glu et al., 2001) or canine (Kelleher et al., 2003) OST and
purified OS-PP-Dols of defined composition have now
revealed unexpected properties of the OST complex. In
agreement with previous studies (Welply et al., 1983; Breuer
and Bause, 1995; Hendrickson and Imperiali, 1995; Gibbs
and Coward, 1999), acceptor-substrate saturation experi-
ments yield linear Lineweaver-Burk plots consistent with a
single binding site for the acceptor-peptide substrate
(Karaoglu et al., 2001; Kelleher et al., 2003). In the case of
the yeast OST, the apparent Km for the acceptor substrate
is enhanced by ∼1.5-fold when Glc3Man9GlcNAc2-PP-Dol
is the donor substrate relative to an assembly intermediate
(Karaoglu et al., 2001). Donor-substrate saturation curves
for Glc3Man9GlcNAc2-PP-Dol were observed to be sig-
moidal, not hyperbolic, and indicate that the yeast OST
binds the donor substrate in a cooperative manner (Karaoglu
et al., 2001). Importantly, donor-substrate saturation curves
obtained with an assembly intermediate (Man9GlcNAc2-PP-
Dol) are also sigmoidal, indicating that a two-part binding
site that recognizes both the terminal glucose residue and
the dolichol-PP-GlcNAc2 moiety cannot account for the
cooperative-binding kinetics of the donor substrate. Two
donor-substrate binding sites and one acceptor substrate
binding site are compatible with a substrate activation
model for the OST, wherein binding of the donor substrate
to a regulatory OS-PP-Dol binding site is a prerequisite for
binding of both the acceptor substrate and a second donor
substrate to the catalytic site. The kinetic analysis of canine
OST isoforms confirmed that higher eukaryotic OST com-
plexes have two independent binding sites for the donor oli-
gosaccharide and further showed that the identity of the
catalytic subunit (STT3A versus STT3B) affected the active
site kinetic parameters, but not the regulatory site kinetic
parameter (Kelleher et al., 2003).
How can a donor-substrate activation model for the OST
explain the selective utilization of the fully assembled OS-
PP-Dol? According to the substrate-activation model we
have proposed (Figure 5), the ability of the OST to discriminate
between the glucosylated and nonglucosylated donor sub-
strates is determined by the ratio of two pairs of interaction
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factors (γ/α and δ/β). The interaction factors describe how
the structure of the OS-PP-Dol molecule bound to the regu-
latory site influences the binding affinity of the catalytic site
for Glc3Man9GlcNAc2-PP-Dol or an assembly intermedi-
ate. Effectively, the substrate-activation mechanism allows
the OS-PP-Dol-binding affinity of the catalytic site to be
fine-tuned to favor the utilization of Glc3Man9GlcNAc2-
PP-Dol when a mixed population of oligosaccharide
donors is present. Because the affinity of the regulatory site
for Glc3Man9GlcNAc2-PP-Dol and Man9GlcNAc2-PP-
Dol is similar (94 and 67 nM, respectively), occupation of
the regulatory site will reflect the composition of the donor
oligosaccharide pool, which under normal physiological
conditions will be enriched in Glc3Man9GlcNAc2-PP-Dol.
When the regulatory site is occupied by Glc3Man9GlcNAc2-
PP-Dol, the relative affinity of the catalytic site for the
donor substrate will favor binding of the fully assembled
donor by ∼1.5-fold (γ/α) relative to an assembly intermedi-
ate. Consequently, the OST will primarily utilize
Glc3Man9GlcNAc2-PP-Dol in vivo both because this com-
pound is the most abundant donor and because of the
homotropic interactions favoring Glc3Man9GlcNAc2-PP-
Dol binding to the catalytic site. When the regulatory site is
occupied by an assembly intermediate (e.g., Man9GlcNAc2-
PP-Dol), the enzyme will display a 7- to 10-fold preference
(δ/β) for Glc3Man9GlcNAc2-PP-Dol relative to an assem-
bly intermediate, hence any available Glc3Man9GlcNAc2-
PP-Dol will be preferentially utilized. What in vivo evidence
supports this kinetic model for donor-substrate selection?
The original yeast alg3 mutant, which is slightly leaky,
preferentially utilizes the residual Glc3Man9GlcNAc2-PP-
Dol to glycosylate proteins in vivo (Verostek et al., 1993).
The latter situation also occurs in wild-type yeast cells as
the dextrose in growth media is depleted during late log phase
(Trimble et al., 1980) or in human CDG fibroblast cell lines
that have leaky mutations in human ALG genes (Korner et al.,
1999). The complete absence of Glc3Man9GlcNAc2-PP-Dol
from the donor oligosaccharide pool, as occurs in alg gene
null mutants (e.g., alg6Δ; Reiss et al., 1996), causes a reduc-
tion in the in vivo glycosylation of glycoproteins in accord
with the reduced transfer rate predicted by the kinetic
model. For a more detailed presentation of this model for
donor-substrate selection by the eukaryotic OST, we refer
the interested reader to Karaoglu et al. (2001).
Trypanosomes (de la Canal and Parodi, 1987) and many
other protists (Samuelson et al., 2005) assemble OS-PP-Dols
that lack glucose residues, hence these organisms provide use-
ful experimental systems to analyze donor-substrate selection
by the OST. Unlike the yeast and mammalian OST which
select Glc3Man9GlcNAc2-PP-Dol from a complex mixture of
dolichol-linked oligosaccharides, the trypanosome OST does
not show a preference for either the optimal vertebrate donor
(Glc3Man9GlcNAc2-PP-Dol) or the native donor (e.g.,
Man9GlcNAc2-PP-Dol for Trypanosoma cruzi) relative to
other compounds in a donor oligosaccharide mix (Bosch
et al., 1988). These results suggest that donor-substrate selec-
tion is a property of the multi-subunit OST complexes that
are expressed in organisms that assemble the triglucosylated
oligosaccharide donors. It will now be important to examine
the kinetic properties of the OST from organisms that are
Fig. 5. A model for donor-substrate selection by the Saccharomyces cerevisiae OST. The OST is proposed to have two OS-PP-Dol binding sites: a 
regulatory (R) site and a catalytic (S) site. The location of the regulatory site is not known; Stt3 contains the catalytic site. Binding of OS-PP-Dol to the 
regulatory site activates the catalytic site for binding of OS-PP-Dol and the acceptor tripeptide (P). The affinity ratio (G3/M9) is the ratio of the interaction 
factors described in the text. The model depicts how Glc3Man9GlcNAc2-PP-Dol will be preferentially utilized even when an assembly intermediates 
(e.g., Man9GlcNAc2-PP-Dol) is more abundant.
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predicted to have simpler OST complexes (Figure 2C and D)
to determine whether cooperative binding of OS-PP-Dol can
be ascribed to the presence of a specific subunit.
Conclusions
The conclusion that STT3 proteins are the active site sub-
units of the OST in eukaryotes, archaebacteria and certain
eubacteria ended a three-decade long search for the protein
that catalyzes this critical step in glycoprotein biosynthesis.
The discovery that the eubacterial enzyme is a single sub-
unit (PglB), rather than the 300-kDa hetero-oligomer
present in most eukaryotes, greatly improves the prospect
that a high-resolution structure of the OST can be obtained
in the foreseeable future. Although the crystallization of a
membrane protein is not a trivial endeavor, the successful
expression of C. jejuni PglB in E. coli has paved the way for
progress in this area. The expression of PglB in E. coli will
also allow investigators to examine the OST mechanism in
a simpler system. At the same time, it remains clear that
there are important differences between the eubacterial and
eukaryotic OST in terms of donor- and acceptor-substrate
specificity and donor-substrate selection. We can anticipate
that analysis of the OST from diverse organisms will reveal
new and unexpected findings about this important enzyme.
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